Noven To Present At UBS Global Life Sciences Conference

-- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that Peter Brandt, Noven’s President & Chief Executive Officer, is scheduled to present an update on Noven’s business and prospects at the UBS Global Life Sciences Conference in New York City on Monday, September 22nd at 12:30 p.m. ET. The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter for at least two weeks at the same site.

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven’s business and operations are focused in three principal areas – transdermal drug delivery, the Novogyne joint venture, and Noven Therapeutics, Noven’s specialty pharmaceutical unit. For more information about Noven Pharmaceuticals, visit www.noven.com.

Contact:
Alina Bowman
Investor Relations Coordinator
305-253-1916